- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: US Pledges Aid to India; Vaccination Rates in Essential Workers, Republicans; Waivers for COVID-19–Related Fees
United States pledges medical aid to India amid COVID-19 surge; poll on attitude toward COVID-19 vaccines spotlight hesitancy among Republicans, non–health care essential workers; waiver fees for COVID-19-related treatments ending for insured patients of several health plans.
US Pledges Medical Aid to India Amid COVID-19 Spikes
Amid marked spikes in cases of COVID-19 reported in India, the United States pledged to provide more medical aid to the country, which will include raw materials for vaccine production, test kits, ventilators, and personal protective equipment. NPR reported that 350,000 new daily cases of COVID-19 were reported yesterday in India, marking the fourth consecutive day that the country broke the record for most cases in a day. The United States is also said to be potentially deploying a team of public health advisers from the CDC and US Agency for International Development to assist health officials in India and the US Embassy.
Vaccine Attitude Polls Spotlight Reluctant Essential Workers, Republicans
According to a poll by CBS News, 6 in 10 Americans say they will get vaccinated or report having received at least one dose, with the remaining 4 in 10 providing responses of "maybe" (18%) or "no" (22%), marking a 4-point decrease in the percentage of Americans who expressed hesitancy last month. In delineating groups who may most likely be reluctant to receive a vaccine, the Kaiser Family Foundation COVID-19 Vaccine Monitor indicated that more than 20% of non–health care essential workers say they will definitely not get the vaccine, which is higher among Republican or Republican-leaning essential workers with 4 in 10 (40%) not intending to be vaccinated.
Insurers Moving to End COVID-19 Treatment Fee Waivers
With many insurers having voluntarily waived all deductibles, copayments, and other costs related to COVID-19 infection for insured patients last year, an article by Kaiser Health News highlights how a growing number of insurers are quietly ending those fee waivers for COVID-19 treatment on some or all policies. Although cost sharing for testing has been waived through guidance reinforced by the Biden administration, treatment has conversely not been addressed, which can prove financially burdensome for patients who fall significantly ill with the virus and require hospitalization.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
